Ontex Group (ONTEX) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
28 Oct, 2026Executive summary
Transformation advanced: Focus to Value delivered €45 million savings in 9M, while Q3 adjusted EBITDA fell 49% YoY amid sharp input-cost inflation and slower pricing pass-through.
FY 2026 adjusted EBITDA outlook cut to €143–148 million; free cash flow expected at €(10)–0 million and year-end leverage capped at 3.75x.
2027 priorities are cash generation, faster savings implementation and adult care volume growth to strengthen the balance sheet.
Financial highlights
Q3 revenue was €427.9 million, down 3.9% YoY reported and 4% LFL; 9M revenue was €1,282.7 million, down 3.2%.
Q3 adjusted EBITDA was €25.9 million versus €50.6 million; 9M adjusted EBITDA was €104.1 million versus €136.8 million, down 24%.
Q3 operating profit was €0.4 million versus €29.3 million; 9M operating loss was €117.2 million versus €72.1 million profit.
Q3 input and other cost inflation had a net €18 million adverse impact; lower volumes reduced revenue by €7 million, partly offset by €16 million of Focus to Value savings.
Outlook and guidance
FY 2026 adjusted EBITDA guidance reduced from €165–180 million to €143–148 million; Q4 expected at €39–44 million.
FY 2026 free cash flow outlook improved to €(10)–0 million from €(25)–(10) million; year-end leverage is expected not to exceed 3.75x, versus prior guidance of 3.5x.
Q4 pricing contribution is expected to increase, with raw material costs slightly below Q3 levels; savings and higher seasonal volumes support EBITDA, partly offset by Russian deconsolidation.
2027 focus remains cash generation through accelerated savings and adult care growth, alongside continued transformation investment.
Latest events from Ontex Group
- Revenue and EBITDA declined, but transformation and cost savings drove positive free cash flow.ONTEX
Q2 2026 - Revenue and EBITDA declined, but adult care grew and net debt was reduced.ONTEX
Q1 2026 - Revenue and EBITDA fell in 2025, but debt reduction and EBITDA growth are targeted for 2026.ONTEX
Q4 2025 - H1 2025 saw revenue and margin declines, but divestments reduced net debt and H2 recovery is expected.ONTEX
Q2 2025 - H1 2025 saw a 4% revenue and 22% EBITDA drop, but H2 recovery is expected.ONTEX
Q2 2025 TU - Q3 delivered 29% EBITDA growth, margin gains, and key transformation milestones, with guidance confirmed.ONTEX
Q3 2024 - Strong H1 2024 results and raised outlook as volume growth and cost savings boost profitability.ONTEX
Q2 2024 - Q1 2025 margin resilience and strategic actions support a positive 2025 growth outlook.ONTEX
Q1 2025 - Strong volume-driven growth, margin expansion, and lower leverage set the stage for 2025.ONTEX
Q4 2024